Press Releases

 Filter by Provider

Abridge, the leading enterprise-grade AI platform for clinical conversations, today announced content partnerships with NEJM Group, publisher of the New England Journal of Medicine, and the American Medical Association, publisher of the JAMA Network, which brings JAMA together with 11 specialty journals and JAMA Network Open.

Leadiant Biosciences, Inc. today announced that Health Canada has approved Cysklar® (cysteamine ophthalmic solution) 0.44%, a topical eye drop solution indicated for the treatment of corneal cystine crystal accumulation in people with cystinosis.

Evercore (NYSE: EVR) will release its first quarter 2026 financial results on Wednesday, April 29, 2026 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day.

TreviPay, a global B2B payments infrastructure partner, announced today the return of TreviPay Crossroads, the B2B payments conference, taking place November 8–10, 2026 at the Loews Hotel in Kansas City, Missouri.

Any Class, Every Repair. Fleets Can Now Centralize Repair Operations Across All Vehicles.

Teledyne Technologies Incorporated (NYSE:TDY) will hold a conference call to discuss its first quarter 2026 results on Wednesday, April 22, 2026, at 8:00 a.m. Pacific. A press release with the first quarter financial results will be issued before the opening of the New York Stock Exchange on Wednesday, April 22, 2026.

Momentus Inc. (NASDAQ: MNTS) (“Momentus”), a U.S. commercial space company specializing in satellite technology, space transportation, and in‑orbit services, today announced their CEO John Rood will moderate a high‑level international panel at The Space Symposium titled “The Global Economics of Space” on Thursday, April 16, bringing together senior leaders from national space agencies, global economic institutions, and the commercial space sector. The session will run from 2:45 p.m. to 3:30 p.m. in the International Center South at the Broadmoor in Colorado Springs, Colorado.

SmartBear, a leading provider of software quality and visibility solutions, today announced new Swagger capabilities to better enable organizations to govern, validate, and scale APIs even as AI accelerates software development. The innovations will help ensure that what gets built works as intended and empower teams to move faster with confidence.

PARSIPPANY, N.J. and TEL AVIV, Israel, April 15, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of Home Ground™ Schizophrenia Community, a new online platform designed to support people living with schizophrenia and their care partners with community-informed and experienced-based information and support.

DALLAS, April 15, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST; SATA) (“Strive” or the “Company”) today announced a SATA dividend rate increase of 25 bps from 12.75% to 13.00% on its Variable Rate Series A Perpetual Preferred Stock (the “SATA Stock”), effective for monthly periods commencing on or after April 15, 2026.  

Continuing education firm to be integrated with October Three’s Retirement Learning Center

Ingelheim, Germany and Shanghai, China/Cambridge, Mass. – 15 April, 2026 – Boehringer Ingelheim and Zai Lab (NASDAQ: ZLAB; HKEX: 9688) today announced a clinical collaboration focused on pioneering a dual DLL3-targeting combination. The Phase Ib/II study will assess the safety, tolerability, and initial clinical activity of combining obrixtamig, Boehringer Ingelheim’s DLL3/CD3 T-cell engager, with zocilurtatug pelitecan (zoci; formerly ZL‑1310), Zai Lab’s DLL3-targeting ADC. The study will enroll patients with poorly differentiated NECs and extensive stage SCLC (ES-SCLC); diseases where patients urgently need more effective treatment options. 

ESCONDIDO, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. ("OSS" or the "Company") (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today issued a shareholder letter, which reviews the progress it made in 2025 and the Company's expectations for 2026. 

NYCPA Celebrates Young CPAs in New York

Celebration, FL, April 15, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today announced that it has acquired the remaining 49% ownership interest in its franchisee, La Rosa Realty Orlando LLC (“LRRO”). With this transaction, LRRO is now a wholly owned subsidiary of La Rosa.

DUBLIN and BRIDGEWATER, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced that it will report first quarter 2026 financial results and conduct a conference call on Wednesday, April 29, 2026. The Company will issue a press release detailing its first quarter 2026 financial results in the pre-market hours, followed by a conference call with senior management at 8:00 a.m. ET.

AUSTIN, Texas, April 15, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced publication in Epilepsia of preclinical data showing that simufilam attenuated seizure progression in a well-accepted mouse model of severe TSC-related epilepsy1. The results support the continued evaluation of simufilam for the treatment of TSC-related epilepsy, which affects approximately 45,000 people in the U.S.2,3. Simufilam is an oral small molecule intended to modulate filamin A protein.

SEATTLE and SINGAPORE, April 15, 2026 (GLOBE NEWSWIRE) -- Callio Therapeutics, a biotherapeutics company advancing dual-payload antibody-drug conjugates (ADCs) with a targeted, multi-mechanism approach to cancer treatment, today announced a poster presentation on CLIO-8221 at the American Association of Cancer Research (AACR) Annual Meeting 2026 (April 17-22, San Diego). CLIO-8221, currently being evaluated in an ongoing Phase 1 trial, is a first-in-class dual-payload ADC, engineered for targeted delivery of two payload classes, a topoisomerase 1 (Topo1) inhibitor and an ATR inhibitor, to HER2-expressing tumors.

BOSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Folia Health announces the launch of Burden and Real-world Assessment of Caregiver Voice and Experiences in Prader-Willi syndrome (BRAVE-PWS), a fully remote observational study, sponsored by Soleno Therapeutics (NASDAQ: SLNO), designed to better understand the real-world experience of caregivers supporting individuals with Prader-Willi syndrome (PWS). The study will use Folia’s app-based platform to collect Home-Reported Outcomes (HROs) and longitudinal caregiver-reported data over six months, helping researchers characterize the day-to-day experience associated with PWS and identify the factors that most affect caregiver well-being and household functioning.

New Growth Agent integrates MX’s data-driven intelligence with Primitive’s agentic operating system to redefine the scale of human-AI collaboration in modern banking

WEST PALM BEACH, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (“SUNS”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it will release its financial results for the first quarter ended March 31, 2026, on Thursday, May 14, 2026, before market open. Management will review SUNS’ financial results at 10:00 am ET via webcast available on the Investor Relations website at ir.sunriserealtytrust.com. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event.

Institutional Clients Can Now Trade Derivatives with a Principal Dealer Directly from Custody — Eliminating Counterparty Risk While Preserving Full Market Access

Medford, OR, April 15, 2026 (GLOBE NEWSWIRE) -- Next Wednesday, April 22, 2026, The Human Bean is hosting its annual Earth Day Giveback at all U.S. locations. Every drink sold plants one tree through Trees for the Future, an international nonprofit with 30+ years of experience planting hundreds of millions of trees and teaching sustainable farming practices to coffee farmers worldwide.

SAN FRANCISCO, April 15, 2026 (GLOBE NEWSWIRE) -- Following its prior announcement that it has entered into a definitive agreement to sell the Allbirds brand and footwear assets to American Exchange Group, which intends to continue to build on Allbirds’ legacy and deliver compelling products to Allbirds’ customers (the “Asset Sale”), Allbirds, Inc. (Nasdaq: BIRD) (the "Company") today announced the execution of a definitive agreement with an institutional investor for a $50 million convertible financing facility (the “Facility”). The Facility, which is expected to close during the second quarter of 2026, will enable the Company to pivot its business to AI compute infrastructure, with a long-term vision to become a fully integrated GPU-as-a-Service (GPUaaS) and AI-native cloud solutions provider. In connection with this pivot, the Company anticipates changing its name to “NewBird AI.”

Kei will serve as Audit Committee Chair, a key appointment as the company prepares to enter the U.S. public markets

MARKHAM, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of April 2026, which is payable on May 15, 2026 to shareholders of record at the close of business on April 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).

Division surpasses $835 million in total credits since inception, with significant momentum driven by recent years of expansion in historic rehabilitation and community revitalization nationwide

MIAMI, April 15, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that the Company will give an oral presentation and multiple poster presentations at the 21st Immunology of Diabetes Society (IDS) Congress being held April 20-24, 2026, in Brisbane, Australia. Data to be presented will highlight SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for newly diagnosed Stage 3 T1D patients.

Mastercard and BNP Paribas veteran to accelerate expansion of Reward across key global markets as Rezolve Ai deepens its position at the intersection of banking, commerce and AI

SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will participate in RedChip’s upcoming virtual investor conference, “Biotech Resurgence: Platforms and Pipelines of Today’s Innovators,” taking place April 16, 2026, from 9:30 a.m. to 4:00 p.m. E.T.

NEWARK, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- NeenOpal, a global leader in high-velocity AI automation and cloud modernization, announced today that it has achieved the Amazon Web Services (AWS) AI Competency in the Generative AI and Agentic AI categories. This specialization recognizes NeenOpal as an AWS Partner that helps customers and the AWS Partner Network (APN) drive the advancement of services, tools, and infrastructure pivotal for implementing AI technologies, including both generative and autonomous AI systems.

LONDON, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announced that it has filed its interim condensed consolidated financial results for the three and nine months ended February 28, 2026, and is pleased to provide the following highlights. Unless otherwise indicated, all financial information in this press release is reported in Canadian dollars.

WEST PALM BEACH, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- AFC today announced that it will release its financial results for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, before market open. Management will review AFC’s financial results at 10:00 am ET via webcast available on the Investor Relations section of AFC’s website found here AFC -- Investor Relations. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event.

ACMA National Conference features leaders and professionals affiliated with case management and transitions of care taking place April 20-23 in Orlando, Florida

Strategic partnership makes AMC’s popular and critically acclaimed content accessible to buyers through a single access point

New conversational interface makes it easy for teams to launch, monitor, and guide agentic PXM workflows without technical expertise

Following its 2026 Annual Member Summit, AMGTA today released Additive Manufacturing in Resource-Efficient Manufacturing Systems, an independent report establishing how additive manufacturing should be evaluated, communicated, and deployed across part, system, and enterprise levels.

Regulatory News:

Options Technology (Options), a leading provider of financial services infrastructure, today announced major enhancements to its cutting-edge, real-time monitoring and alerting tool - AtlasVision.

After Peptide Sciences left patients mid-process, many individuals were suddenly forced to reassess ongoing peptide protocols without guidance. This disruption has created urgency, confusion, and increased risk around next steps. California Trim Clinic is helping patients navigate this transition with structured, physician-guided care designed to restore clarity, safety, and continuity.

MBP Global LLP is pleased to announce that Jatinder Singh will join the firm as a Tax Partner, effective April 15, 2026. Her appointment further enhances the firm’s capabilities in delivering sophisticated tax solutions to clients navigating complex U.S. and international regulatory environments.

Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medical Cannabis Opportunity

East Coast Commercial introduces financing options for commercial real estate investors, providing access to loan programs designed to support property acquisition, refinancing, and development across multiple commercial property sectors in the United States.

East Coast Commercial (732-740-2709) introduces financing solutions for new commercial construction projects, supporting developers with structured lending aligned to project phases, capital requirements, and changing commercial real estate development demands across multiple sectors.

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2026 / Classover Holdings Inc. (NASDAQ:KIDZ) ("Classover" or the "Company"), an AI-driven education company, today announced that it has entered into a strategic collaboration with Luka, a developer of intelligent companion and educational robotics systems, to jointly explore the co-development of AI-driven learning scenarios in the North American market.

Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - Vital Infrastructure Property Trust (TSX: VITL.UN) (the 'REIT' or 'Vital Infrastructure'), a...

Viant Technology Inc. (NASDAQ: DSP), a leader in CTV and AI-powered programmatic advertising, today announced it has entered into a definitive agreement to acquire TVision Insights, the only attention measurement provider delivering second-by-second, eyes-on-screen attention, co-viewership and in-room presence for TV.

LOS ANGELES, April 15, 2026 (GLOBE NEWSWIRE) -- CrownGuard Capital LLC, a direct balance sheet lender specializing in structured commercial real estate financing, is pleased to announce the successful closing of a $22,000,000 bridge loan to support the acquisition and development of a premier beach house property in Southern California.

Eddie and Kelley McGrath to receive Cardinal Cushing Award at 2026 Springtime Gala, honouring their philanthropy, recovery advocacy, and community impact.

LONDON, April 15, 2026 (GLOBE NEWSWIRE) -- A new white paper entitled “Inside the Science: A Major Step Forward for Knee Osteoarthritis” has been released which heralds the dawn of a new era of treatments for knee osteoarthritis (OA) that can offer a viable alternative to surgery on the NHS, currently facing a backlog of patients. Launched to coincide with the first major conference in the annual industry calendar – BASK 2026 (British Association of Surgery for the Knee) taking place on April 14-15th 2026 in Glasgow, the paper has been commissioned by Contura Orthopaedics Ltd.